Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMPH.L Regulatory News (MPH)

  • There is currently no data for MPH

Distribution Agreement

21 Aug 2006 07:01

Marchpole Holdings PLC21 August 2006 Marchpole Holdings plc ("Marchpole") Major distribution agreement for Emanuel Ungaro brand into UAE Marchpole Holdings plc, the fast growing fashion brand management group, ispleased to announce it has today signed a distribution agreement with Dubaibased BTC Group International, for the Emanuel Ungaro brand to be sold in theUnited Arab Emirates. The contract is initially for 5 years, beginning with the 2007 Spring/Summercollection, with an opportunity to extend the agreement. Under the terms of thecontract, BTC will open between three and five exclusive stores within the fiveyear term. The contract is safeguarded with minimum guarantees. BTC is one of the leading wholesalers and retailers for prestigious high fashionbrands in the UAE. Founded in 1998 in Dubai, the Company offers exclusivity fora number of world wide fashion labels including Karl Lagerfeld. Following Marchpole's acquisition in March 2006 of Moda America, the US licenseefor Emanuel Ungaro, which has brought further growth opportunities in the USA,the Company owns the worldwide licence for Emanuel Ungaro. The Emanuel Ungarobrand is already established in Europe and Asia and today's distributionagreement opens up opportunities to benefit from the lucrative Gulf marketplace. Marchpole's Executive Deputy Chairman, Michael Morris, commented: "This agreement is a major breakthrough into the fast growing Gulf marketplaceand one which confirms the significant growth potential of the Ungaro brand. Itis yet further progress towards our strategy to become a global fashion brandmanagement group." - ends - For further information, please contact : Emma KentBell Pottinger Corporate & Financial 020 7861 3232 John Harrison, Finance DirectorMarchpole 020 7908 7777 Note to Editors : • Marchpole Holdings plc ("Marchpole") is an international brand management group that designs, produces and sells clothing and accessories for eight globally recognised fashion labels. It operates in all of the world's main markets - UK, mainland Europe, Asia and the USA • Its respected brands include YSL, Boateng, Emmanuel Ungaro, Ungaro, Jean-Charles de Castelbajac ("JCC"), Jean-Charles de Castelbajac / Rossignol, Jean-Charles de Castelbajac/Okaidi and Homebody • Marchpole is renowned for its integrated approach to brand management, taking a brand from concept to design studio to the customer interface. It is not a clothing manufacturer • The Group has grown considerably in the past 3 years, from a licensee with one core licence (YSL menswear) - to today's international business that manages its brands across a multitude of clothing lines and accessories • Marchpole's recent acquisition (March 2006) of Moda America - the US licensee for leading designer Emanuel Ungaro - brings further growth opportunities in the UK and America and strengthens the company's relationship with Ungaro • The acquisition also allows the company to launch the Ungaro brand, already established by Marchpole in Europe and Asia, into the US, Canada and South America. The acquisition also allows the company to re-launch JCC into America with effect from autumn/winter 2006 • Marchpole will launch the diffusion Ungaro Homme collection in the UK from Spring/Summer 2007 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
10th Sep 20191:00 pmRNSNotice of Results
6th Sep 20197:00 amRNSBlock listing Interim Review
4th Sep 20191:00 pmRNSMereo announces phase 2b data at ASBMR Meeting
16th Aug 20191:51 pmRNSDirector/PDMR Shareholding
15th Aug 20194:59 pmRNSPDMR Shareholding
12th Aug 20194:41 pmRNSSecond Price Monitoring Extn
12th Aug 20194:35 pmRNSPrice Monitoring Extension
9th Aug 20194:35 pmRNSPrice Monitoring Extension
31st Jul 201912:51 pmRNSDirector Declaration
25th Jul 20194:56 pmRNSPDMR Shareholding
24th Jul 201910:08 amRNSDirector/PDMR Shareholding
19th Jul 20191:21 pmRNSDirector/PDMR Shareholding
16th Jul 20191:00 pmRNSAppointment of Richard Francis
15th Jul 20191:00 pmRNSSuccessful Type B Meeting with U.S. FDA
8th Jul 20193:54 pmRNSHolding(s) in Company
3rd Jul 20194:41 pmRNSSecond Price Monitoring Extn
3rd Jul 20194:35 pmRNSPrice Monitoring Extension
27th Jun 20193:33 pmRNSHolding(s) in Company
26th Jun 20194:36 pmRNSHolding(s) in Company
21st Jun 20191:00 pmRNSConversion of loan note and issue of equity
20th Jun 20197:00 amRNSResult of AGM
13th Jun 20191:00 pmRNSUpdate on Etigilimab (TIGIT) Partnership
30th May 20197:00 amRNSPositive early 6 month data
23rd May 20194:11 pmRNSDirector/PDMR Shareholding
22nd May 20199:45 amRNSPDMR Shareholding
21st May 20193:08 pmRNSDirector/PDMR Shareholding
20th May 20197:00 amRNSNotice of AGM
8th May 20191:53 pmRNSDirector/PDMR Shareholding
7th May 20197:00 amRNSIssue of Warrants
7th May 20197:00 amRNSRe-release: Intention to Purchase Shares
3rd May 20195:00 pmRNSIntention to Purchase Shares by Trustee of EBT
3rd May 20192:02 pmRNSDirector/PDMR Shareholding
1st May 20193:47 pmRNSDirector/PDMR Shareholding
30th Apr 20193:15 pmRNSDirector/PDMR Shareholding
30th Apr 20197:00 amRNSDirector/PDMR Shareholding
30th Apr 20197:00 amRNSPublication of Annual Report and Accounts
29th Apr 20197:00 amRNSPrelims Results for year ended December 31 2018
26th Apr 20193:01 pmRNSDirector/PDMR Shareholding
25th Apr 20193:36 pmRNSHolding(s) in Company
25th Apr 20193:29 pmRNSHolding(s) in Company
24th Apr 20192:30 pmRNSAdmission to Trading
23rd Apr 20192:25 pmRNSCompletion of Merger
18th Apr 20197:00 amRNSMerger Update
15th Apr 20197:00 amRNSSuccessful end of Phase 2 Meeting with FDA
21st Mar 20197:00 amRNSPublication of Form F-4
15th Mar 201911:45 amRNSUpdate on Proposed Combination of Mereo & OncoMed
13th Mar 201911:00 amRNSMereo CEO appointed NED of Elanco Animal Health
6th Mar 20197:00 amRNSBlock Listing Interim Review
5th Mar 20191:32 pmRNSMereo to present at Cowen and Company Conference
22nd Feb 20191:50 pmRNSUpdate on Proposed Transaction with OncoMed

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.